BACKGROUND: Oxidant stress contributes to the pathogenesis of multiple conditions and can be assessed by measuring plasma F(2)-isoprostane concentrations. We hypothesized that oxidant stress is associated with plasma homocysteine concentration and risk factors for atherosclerosis in HIV-infected women. METHODS: We measured plasma F(2)-isoprostane concentrations in a cross-sectional study of 249 HIV-infected women attending the Bronx (NY, USA) site of the Women's Interagency HIV Study and assessed associations with plasma homocysteine concentration and other metabolic parameters by linear regression. RESULTS: In multivariate analysis, hepatitis C virus (HCV) viraemia, waist circumference, homocysteine concentration and serum aspartate aminotransferase level were positively associated with log F(2)-isoprostane concentration (all P<0.005). There was a trend for an inverse association between log F(2)-isoprostane and CD4(+) T-cell percentage (P=0.06). Among women with HCV infection, the FIB-4 index, an indirect marker of liver fibrosis derived from routine laboratory tests, was positively associated with log F(2)-isoprostane concentration. CONCLUSIONS: In this cross-sectional study of HIV-infected women, plasma F(2)-isoprostane concentration was positively associated with homocysteine concentration, as well as HCV infection, abdominal obesity and aspartate aminotransferase level.
BACKGROUND: Oxidant stress contributes to the pathogenesis of multiple conditions and can be assessed by measuring plasma F(2)-isoprostane concentrations. We hypothesized that oxidant stress is associated with plasma homocysteine concentration and risk factors for atherosclerosis in HIV-infectedwomen. METHODS: We measured plasma F(2)-isoprostane concentrations in a cross-sectional study of 249 HIV-infectedwomen attending the Bronx (NY, USA) site of the Women's Interagency HIV Study and assessed associations with plasma homocysteine concentration and other metabolic parameters by linear regression. RESULTS: In multivariate analysis, hepatitis C virus (HCV) viraemia, waist circumference, homocysteine concentration and serum aspartate aminotransferase level were positively associated with log F(2)-isoprostane concentration (all P<0.005). There was a trend for an inverse association between log F(2)-isoprostane and CD4(+) T-cell percentage (P=0.06). Among women with HCV infection, the FIB-4 index, an indirect marker of liver fibrosis derived from routine laboratory tests, was positively associated with log F(2)-isoprostane concentration. CONCLUSIONS: In this cross-sectional study of HIV-infectedwomen, plasma F(2)-isoprostane concentration was positively associated with homocysteine concentration, as well as HCV infection, abdominal obesity and aspartate aminotransferase level.
Authors: Todd Hulgan; Michael Hughes; Xin Sun; Laura M Smeaton; Erin Terry; Gregory K Robbins; Robert W Shafer; David B Clifford; Grace A McComsey; Jeffery A Canter; Jason D Morrow; David W Haas Journal: J Acquir Immune Defic Syndr Date: 2006-08-01 Impact factor: 3.731
Authors: Richard K Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia Correa; Julio Montaner; Mark S Sulkowski; Francesca J Torriani; Doug T Dieterich; David L Thomas; Diethelm Messinger; Mark Nelson Journal: Hepatology Date: 2006-06 Impact factor: 17.425
Authors: Ginger L Milne; Huiyong Yin; Joshua D Brooks; Stephanie Sanchez; L Jackson Roberts; Jason D Morrow Journal: Methods Enzymol Date: 2007 Impact factor: 1.600
Authors: Eva Lonn; Salim Yusuf; Malcolm J Arnold; Patrick Sheridan; Janice Pogue; Mary Micks; Matthew J McQueen; Jeffrey Probstfield; George Fodor; Claes Held; Jacques Genest Journal: N Engl J Med Date: 2006-03-12 Impact factor: 91.245
Authors: Kaare Harald Bønaa; Inger Njølstad; Per Magne Ueland; Henrik Schirmer; Aage Tverdal; Terje Steigen; Harald Wang; Jan Erik Nordrehaug; Egil Arnesen; Knut Rasmussen Journal: N Engl J Med Date: 2006-03-12 Impact factor: 91.245
Authors: Gladys Block; Marion Dietrich; Edward P Norkus; Jason D Morrow; Mark Hudes; Bette Caan; Lester Packer Journal: Am J Epidemiol Date: 2002-08-01 Impact factor: 4.897
Authors: James B Meigs; Martin G Larson; Caroline S Fox; John F Keaney; Ramachandran S Vasan; Emelia J Benjamin Journal: Diabetes Care Date: 2007-06-22 Impact factor: 19.112
Authors: Howard D Strickler; Andrea A Howard; Marion Peters; Melissa Fazzari; Herbert Yu; Michael Augenbraun; Audrey L French; Mary Young; Stephen Gange; Kathryn Anastos; Andrea Kovacs Journal: AIDS Date: 2008-02-19 Impact factor: 4.177
Authors: A C Ross; T Leong; A Avery; M Castillo-Duran; H Bonilla; D Lebrecht; U A Walker; N Storer; D Labbato; A Khaitan; I Tomanova-Soltys; G A McComsey Journal: HIV Med Date: 2011-11-21 Impact factor: 3.180
Authors: Michael S Boger; Aihua Bian; Ayumi Shintani; Ginger L Milne; Jason D Morrow; Husamettin Erdem; Valerie Mitchell; David W Haas; Todd Hulgan Journal: Antivir Ther Date: 2011-12-14
Authors: Matthew B Crist; Vlada V Melekhin; Aihua Bian; Ayumi Shintani; Ginger L Milne; Asha R Kallianpur; Leigh A Dageforde; David W Haas; Todd Hulgan Journal: J Acquir Immune Defic Syndr Date: 2013-12-01 Impact factor: 3.731
Authors: Vicente Estrada; Paloma Geijo; Manuel Fuentes-Ferrer; María Luisa García Alcalde; María Rodrigo; María José Galindo; Agustín Muñoz; Pere Domingo; Esteve Ribera; Jaime Cosín; Pompeyo Viciana; Fernando Lozano; Alberto Terrón; Antonio Vergara; Ramón Teira; Josefa Muñoz-Sánchez; Bernardino Roca; Trinitario Sánchez; José López-Aldeguer; Elisabeth Deig; Francisco Vidal; Enric Pedrol; Manuel Castaño-Carracedo; Teresa Puig; Myriam Garrido; Ignacio Suárez-Lozano Journal: BMC Womens Health Date: 2011-08-04 Impact factor: 2.809
Authors: Todd Hulgan; M Sean Boger; Diana H Liao; Grace A McComsey; Christine A Wanke; Alexandra Mangili; Sharon L Walmsley; Heather McCreath; Ginger L Milne; Stephanie C Sanchez; Judith S Currier; Jordan E Lake Journal: Mediators Inflamm Date: 2014-06-01 Impact factor: 4.711